Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS) : Mediated Anti-tumor Therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Immunology ; 10 (2019). - 707. - eISSN 1664-3224
- Ereignis
-
Veröffentlichung
- (wo)
-
Konstanz
- (wer)
-
KOPS Universität Konstanz
- (wann)
-
2019
- Urheber
- URN
-
urn:nbn:de:bsz:352-2-nhh6lhe727a29
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koerner, Julia
- Horvath, Dennis
- Groettrup, Marcus
- KOPS Universität Konstanz
Entstanden
- 2019
Ähnliche Objekte (12)
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies